Latest On-Demand Webinars

Don't miss this 2-day interactive online event where the experts will be discussing current challenges in safety pharmacology and cardiac physiology, in silico modeling and best practices and evolvements of safety pharmacology methods.

A key step in cannabis oil production is the decarboxylation of naturally produced THCA to psychotropic THC or CBDA to CBD, respectively.

A key step in cannabis oil production is the decarboxylation of naturally produced THCA to psychotropic THC or CBDA to CBD, respectively. To better control this important processing step, we have developed an infrared monitoring solution that can track decarboxylation progress in near real-time.

Current regulatory authorities (WHO, EMA and US FDA) limited the accepted amounts of residual DNA in biological products making it extremely important to have a sensitive method of quantifying residual host cell DNA. Among the methods of detecting residual DNA, qPCR is the most widely used for residual DNA quantitation due to its sensitivity, accuracy, precision, and time-saving capability.

Watch this webinar to learn more about the quality requirements for critical raw material for commercial mRNA production and ongoing projects to optimize the entire mRNA portfolio to meet fit-for-purpose standards.

New trends and challenges are being identified as more cell and gene therapy institutions move toward clinical trials and into commercialization. Closed manufacturing systems are designed to minimize contamination risks and reduce ISO cleanroom requirements. In combination with digital connectivity, these systems enable repeatable, trackable, and GMP-compliant manufacturing processes.

Artificial Intelligence (AI) based on deep learning (DL) is opening new horizons in biomedical research and promises to revolutionize the microscopy field. It is now transitioning from the hands of experts in computer sciences to biomedical researchers.

In this presentation, Morgan Boyle, Lead Microbiologist and Cannabis Science Consultant will discuss the current status of microbial testing requirements and the need for testing standardization throughout the U.S.

In this webinar, Kristina Schwamborn, associate professor in the Institute of Pathology at the Technical University of Munich, will discuss how MALDI-IMS can overcome the limitations of other approaches in the discovery and identification of new classifying marker molecules and profiles.

In this webinar, we will demonstrate how an advanced three-dimensional (3D) microfluidic model of non-alcoholic steatohepatitis (NASH) can be fine-tuned using exogenous stimuli to enhance key features such as fibrosis or inflammation.